| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC2034 |
| Trial ID | NCT03774654 |
| Disease | Chronic Lymphocytic Leukemia | Non-Hodgkin's Lymphoma | Acute Monocytic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-NK cell |
| Treatment | CD19 CAR-NK cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | CD19.CAR Allogeneic NKT for Patients With Relapsed or Refractory B-Cell Malignancies (ANCHOR) |
| Year | 2020 |
| Country | United States |
| Company sponsor | Baylor College of Medicine |
| Other ID(s) | H-44526 ANCHOR |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||||||
|
|||||||||||||